• These results were first presented by Dr. Toni Choueiri at the meeting of the European Society for Medical Oncology (ESMO) 2016, and published in the Journal of Clinical Oncology (Choueiri, JCO, 2016). (businesswire.com)
  • These data are being presented today at the European Society for Medical Oncology (ESMO) 2018 Congress Presidential Symposium at 4:30 - 4:45 p.m. (azbio.org)
  • The data will be presented in a poster discussion session at the European Society of Medical Oncology (ESMO) 2017 Congress, September 8-12, 2017 in Madrid, Spain. (biospace.com)
  • of Memorial Sloan Kettering Cancer Center at the European Society for Medical Oncology (ESMO) Congress 2023. (merus.nl)
  • Novocure, a global oncology company, is set to present new data on Tumor Treating Fields (TTFields) therapy at the European Society for Medical Oncology (ESMO) Congress 2023 in Madrid. (latestnews.top)
  • Over the last years, he also played several leadership roles in medical societies such as ESMO and ASCO. (sciencebusiness.net)
  • He is a member of ASCO, AACR, and ESMO, a peer reviewer for several oncology journals and has contributed to more than 450 peer-reviewed publications. (wavy.com)
  • Reported ongoing complete responses in three of seven patients at the 12-month follow-up in the Phase 1 portion of the ZUMA-1 study of KTE-C19 in chemorefractory DLBCL at the European Society for Medical Oncology (ESMO). (gilead.com)
  • Treatment with the Oncosil device was approved in Europe for clinical use in May 2020, following a prolonged preclinical phase and the presentation of the results of the pivotal PanCO study at the 2020 European Society of Medical Oncology (ESMO) World Congress. (oncosil.com)
  • MammaPrint has been recently recognized as being supported by level 1A clinical evidence by the German Gynecological Oncology Group (AGO) in Germany, the European Group on Tumor Markers (EGTM), and is also recommended for use in other important best-practice guidelines including those of the European Society for Medical Oncology (ESMO). (agendia.com)
  • He is the leading author of the Clinical Practice Guidelines for Advanced Colorectal Cancer (2022) of the European Society of Medical Oncology (ESMO) and co-author of the Esophageal Cancer Guidelines. (incliva.es)
  • He has been elected 2023-2024 President of ESMO, a global society that brings together more than 27,000 oncology professionals from around the world. (incliva.es)
  • Dr. Hortobagyi presented the findings on September 18 at the 2021 European Society of Medical Oncology (ESMO) Congress. (cancer.gov)
  • CAMBRIDGE, Mass. & MILAN, Oct 11, 2010 (BUSINESS WIRE) - AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) were presented at the 35th European Society for Medical Oncology (ESMO) Congress in Milan, Italy. (aveooncology.com)
  • She is member of the scientific committee and faculty on Immunotherapy in the European Society for Medical Oncology, ESMO. (esmo.org)
  • The JUPITER-06 results were first presented in a mini-oral session during the 2021 European Society for Medical Oncology ("ESMO") Congress and later published in Cancer Cell with an editorial preview. (itbusinessnet.com)
  • These educational resources are freely accessible from the World Cancer Report Updates learning platform, which was developed with the support of and in collaboration with the European Society for Medical Oncology (ESMO) . (who.int)
  • The Annals of Oncology is a peer-reviewed medical journal of oncology, published by Elsevier. (wikipedia.org)
  • Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. (hdomst.hr)
  • IRVINE, CA and AMSTERDAM - 6 July 2017 - Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics announces that the 15th St. Gallen International Breast Cancer Guidelines recently published in Annals of Oncology 1 have recommended the MammaPrint ® 70-Gene Breast Cancer Risk-of-Recurrence Test for the third time to help guide treatment decision-making for patients with early-stage breast cancer. (agendia.com)
  • He is also editor-in-chief of Cancer Treatment Reviews and an associate editor of Annals of Oncology. (incliva.es)
  • He has served as President of the Connective Tissue Oncology Society (CTOS), has authored or co-authored more than 300 articles in peer-reviewed journals and has been Section Editor for the Sarcoma Section of Current Oncology Reports since 2000. (wavy.com)
  • Prof. Antoine Italiano is an experienced expert in sarcoma and immuno-oncology with a keen interest in translational research aspects related to sensitivity and resistance to targeted therapies, notably in soft-tissue sarcoma models. (wivb.com)
  • Currently, Dr Liberatore is a Strategic Advisor to GlyTherix Ltd, an Australian immuno-oncology company specializing in developing antibody radiopharmaceuticals for solid tumours. (oncosil.com)
  • GSK's pipeline is focused on immuno-oncology, cell therapy, tumor cell targeting therapies and synthetic lethality. (gsk.com)
  • She actively supports the European cancer patient coalition as scientific committee member in the Immuno-Oncology Academy. (esmo.org)
  • Ipsen remains on track to submit the regulatory dossier for cabozantinib as a treatment for first-line advanced renal cell carcinoma in Europe in the third quarter of 2017. (businesswire.com)
  • We intend to file these important data with European regulatory authorities in the third quarter of 2017. (businesswire.com)
  • the European Society of Gynaecologic Oncology (ESGO), the International Gynaecologic Cancer Society (IGCS) and the American Society of Clinical Oncology (ASCO). (esmo.org)
  • Dr. Eggermont has served as President of ECCO, EORTC, the European Academy of Cancer Sciences and of Cancer Core Europe and was a member of the Board of Directors of ASCO. (wivb.com)
  • In June 2022, Sierra Oncology presented the complete data from the MOMENTUM phase III trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. (gsk.com)
  • He was also the former President of the European Society for Medical Oncology, has served on the Board of Directors of the American Society of Clinical Oncology (ASCO) as well as the American Association for Cancer Research (AACR). (catalannews.com)
  • The JUPITER-02 results were first presented in the plenary session of the American Society of Clinical Oncology ("ASCO") 2021 annual meeting (#LBA2) and subsequently published in detail as the cover article of the September 2021 issue of Nature Medicine . (itbusinessnet.com)
  • The European Journal of Cancer (EJC) is an international multidisciplinary oncology journal, which publishes original research, reviews, and editorial comments on basic and preclinical cancer research, translational oncology, clinical oncology - including medical oncology, paediatric oncology, radiation oncology, and surgical oncology, and cancer epidemiology and prevention. (elsmediakits.com)
  • Prof. Alexander Eggermont specializes in preclinical and clinical / translational oncology and is a specialist in immunotherapy research and the treatment of melanoma and sarcoma. (wivb.com)
  • Member of - European Society of Therapeutic Radiation Oncologists (ESTRO). (wellnessdestinationindia.com)
  • Novocure looks forward to sharing these insights with leading medical oncologists and continuing to learn from them. (latestnews.top)
  • American Journal of Clinical Oncology is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, GYN oncologists, and pediatric oncologists. (hdomst.hr)
  • But multiple factors can influence oncologists' choice of which drug to use for which patients, said Melissa McShane, M.D., of the Breast Cancer Oncology Program at Fox Chase Cancer Center. (cancer.gov)
  • This acquisition expands our innovative oncology portfolio, demonstrating our commitment to improving patient outcomes and creating value for shareholders. (gsk.com)
  • He joined Institute of Oncology at Jaypee Hospital as Director, Radiation Oncology. (wellnessdestinationindia.com)
  • Baselga has successfully combined his latest functions in New-York with his duties in Barcelona, as the President of the Scientific Committee of the Vall d'Hebron Institute of Oncology (VHIO). (catalannews.com)
  • He is a Senior Consultant in Hematology and Oncology, Head of the Sarcoma Center and the Hyperthermia Unit at the University Hospital of Ludwig-Maximilians-University (LMU) Munich. (wivb.com)
  • In 2016, he joined the faculty at MD Anderson Cancer Center, where his current clinical focus is aimed to expand the treatment potential for musculoskeletal and lung metastases as well as pediatric oncology treatments, venolymphatic treatments, and imaging optimization. (mdanderson.org)
  • He is Professor of Clinical and Translational Immunotherapy, University Medical Center, and Chief Scientific Officer at the Princess Máxima Center for Pediatric Oncology, Utrecht (The Netherlands). (wivb.com)
  • Richard Kim, MD, from the Moffitt Cancer Center, University of South Florida College of Medicine, provides expert commentary on key abstracts and posters presented at the 2021 annual meeting of the European Society for Medical Oncology. (ccanewsonline.com)
  • Beyond clinical duties, he applies his education from the Harvard School of Public Health in the role of Patient Safety and Quality Officer (2018-2021) and Clinical Medical Director (2021-current) for the Department of Interventional Radiology, a diverse and proactive group of approximately 150 health care professionals. (mdanderson.org)
  • Emile Voest is currently director of Cancer Core Europe, a collaboration of 7 top comprehensive cancer centers in Europe and was Executive Medical Director of the Netherlands Cancer Institute (NKI) until 2021. (sciencebusiness.net)
  • Antoine Yver took over in 2021 as Chief Medical Officer of Centessa Pharmaceuticals, Inc. He began his oncology development career at Rhône Poulenc Rorer Inc. in 1990. (sciencebusiness.net)
  • In 2021, two indications for the treatment of NPC were approved by the China National Medical Products Administration ("NMPA"), thereby making toripalimab the world's first immune checkpoint inhibitor approved for the treatment of NPC. (itbusinessnet.com)
  • Baselga had worked as the Chief of the Division of Hematology/Oncology at Massachusetts General Hospital (MGH) and as the Associate Director of the MGH Cancer Centre. (catalannews.com)
  • At the European Society for Medical Oncology 2022 Congress, Triumvira presented interim data from the ongoing TACTIC-2 Phase 1/2 trial that demonstrated the safety and preliminary efficacy of TAC01-HER2 in patients with HER2-positive solid tumors regardless of level of expression. (innovationfactory.ca)
  • Dr. De worked as Registrar, Pool Officer and Later as Assistant Professor in the Department of Radiation Oncology at BR Ambedkar Institute, Rotary Cancer Hospital(BRIRCH),AIIMS. (wellnessdestinationindia.com)
  • He is Professor of Medical Oncology at the University of Utrecht (UMC) since 1999 and leads his research group at the NKI and Oncode Institute. (sciencebusiness.net)
  • He previously served as the General Director of the Gustave Roussy Cancer Center Campus Grand Paris, is a Professor Emeritus of Oncology at the Paris-Sud University, and a Professor Emeritus of Oncological Surgery at the Erasmus University Rotterdam. (wivb.com)
  • He is the Robert R. Herring Distinguished Professor of Medicine and Medical Director of the Sarcoma Center at The University of Texas MD Anderson Cancer Center, Houston TX (USA). (wavy.com)
  • Anthony W. Kim M.D., M.S. is the Chief of Division of Thoracic Surgery and Professor of Clinical Surgery in the Department of Surgery at the Keck School of Medicine and the Vice Chair, Clinical Operations for the Department of Surgery at the University of Southern California in Los Angeles, California. (aats.org)
  • He leads the Medical Oncology Department at the University Hospital of Valencia and is Professor of Medicine at the University of Valencia. (incliva.es)
  • Inge Marie Svane, MD, PhD is Professor in Clinical Cancer Immune Therapy at the University of Copenhagen, Director of National Center for Cancer Immune Therapy (CCIT-DK), Herlev and Gentofte Hospital, and Chief Physician specialized in melanoma at the Department of Oncology at Copenhagen University Hospital, Herlev, Denmark. (esmo.org)
  • Examples from New Zealand and the USA will be provided by the guest lecturers: Professor Diana Sarfati, Chief Executive for Te Aho o Te Kahu - Cancer Control Agency, New Zealand, and Dr Ahmedin Jemal, Senior Vice President of the Data Science Department of the American Cancer Society (ACS), USA. (who.int)
  • ESMOis the leading European oncology professional organization, committed to advancing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care. (aveooncology.com)
  • He is presently Chief Oncologist at the Dept. of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark and Medical Director of the Nordic Society of Gynaecologic Oncology-Clinical Trial Unit (NSGO-CTU). (esmo.org)
  • The editor-in-chief is Fabrice André (Villejuif, France). (wikipedia.org)
  • He is also a Fellow of the National Institutes of Health's National Cancer Institute (NIH-NCI), a strategic advisor to the Comprehensive Cancer Center Munich CCCM (Germany) and is currently Editor-in-Chief of the European Journal of Cancer. (wivb.com)
  • I'm Eric Topol, editor-in-chief of Medscape. (medscape.com)
  • CAMBRIDGE, Mass., November 7, 2023 - Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today provided a business update and reported financial results for the third quarter ended September 30, 2023. (mersana.com)
  • SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced the appointment of Andrew P. Aromando as Chief Operating Officer. (researchpool.com)
  • The European Journal of Cancer (EJC) integrates preclinical, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. (hdomst.hr)
  • From 2009 to 2016, he led global oncology development at AstraZeneca, delivering TAGRISSO and LYNPARZA, including Senior Vice President, GMD Head of Oncology and Lead, China GMD (2013-2016). (sciencebusiness.net)
  • Announced planned oral and poster presentations of KTE-C19 clinical and manufacturing data at the 2016 annual meeting of the American Society of Hematology . (gilead.com)
  • He has founded and leads several innovative precision medicine initiatives in oncology. (sciencebusiness.net)
  • His latest studies address the role of liquid biopsy as a tool for precision medicine in Oncology. (incliva.es)
  • Board of Directors: Gynaecologic Cancer Inter-Group (GCIG), Founding Member and President (2020-2022): European Network of Gynaecological Oncological Trials Group (ENGOT), Board of Directors & Clinical Advisor: Karyopharm Therapeutics Inc. Boston, USA, Board of Directors: Metamark Genetics Inc. Boston, USA, Board of Directors: Sera Prognostics Inc. Salt Lake City, USA. (esmo.org)
  • After ten years at Sony France as Chief Financial Officer (2000-2002), and then General Secretary, she was appointed Chief Financial Officer of Europacorp Group in 2011. (sciencebusiness.net)
  • There is a major unmet need in the treatment of advanced or metastatic ER+/HER2- breast cancer after resistance builds in the earlier lines of treatment" commented Elcin Barker Ergun , Chief Executive Officer of the Menarini Group. (aap.com.au)
  • Chief Executive Officer of Triumvira. (innovationfactory.ca)
  • Andrew is an outstanding addition to Ambrx," said Daniel J. O'Connor, President and Chief Executive Officer of Ambrx. (researchpool.com)
  • He also worked as A HOD & Chief Radiation Oncologist at various private hospitals in Delhi. (wellnessdestinationindia.com)
  • Prof. Shreyaskumar Patel is a medical oncologist focusing on soft tissue sarcomas (STS), with clinical research interests including systemic therapy for sarcomas, GISTs, and other tumors originating in bone and soft tissues. (wavy.com)
  • Doctors will probably start testing patients soon after diagnosis to see whether they're suited to treatment with Keytruda and can forgo the many side effects of chemotherapy, said Stefan Zimmermann, a chief oncologist at the Cantonal Hospital of Fribourg, Switzerland. (lifeboat.com)
  • On September 21, 2022, I presented an overview of key abstracts on biliary tract cancer (BTC) presented at the 2022 annual meeting of the European Society for Medical Oncology. (ccanewsonline.com)
  • Sierra Oncology submitted a New Drug Application to the US Food and Drug Administration in June, and GSK anticipates a regulatory submission in Europe in the second half of 2022. (gsk.com)
  • IMDZ ), a clinical-stage immunotherapy company focused on oncology, today announced positive topline data from its interim analysis of the ongoing, randomized Phase 2 trial evaluating CMB305 in combination with atezolizumab (TECENTRIQ ® ) or atezolizumab alone in 88 soft tissue sarcoma patients. (biospace.com)
  • Oncolytics Biotech ® and SOLTI Present Clinical Breast Cancer Data Highlighting Pelareorep-Induced Anti-Tumor T Cell Responses at The Society for Immunotherapy of Cancer Annual Meeting - Oncolytics Biotech ® and SOLTI-Innovative Breast Cancer Research today announced the publication of an electronic poster with clinical data from the AWARE-1 window-of-opportunity breast cancer study at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting. (financialnewsmedia.com)
  • She has pioneered the field of cancer immunotherapy in Denmark, building up CCIT-DK, a translational research center in a leading European position. (esmo.org)
  • She became a Fellow of the European Committee on Sexual Medicine in 2018 and has pursued additional training in sexual medicine through the European Society of Sexual Medicine, the International Society for the Study of Women's Sexual Health, and the American Association of Sexuality Counselors Educators and Therapists. (rochester.edu)
  • She became a Fellow of the European Committee on Sexual Medicine in 2018. (rochester.edu)
  • Prof. Patel is a member of the SARC Scientific Steering Committee, Chair of the Medical Advisory Board and a member of the Board of Directors of the Chordoma Foundation. (wavy.com)
  • At the time of his appointment he was the author or co-author of over 300 peer-reviewed articles and publications, and one of the founding editors-in-chief (with Lewis C. Cantley) of the AACR's new journal Cancer Discovery . (catalannews.com)
  • Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, researchers, and the global medical community. (hdomst.hr)
  • Cancer, an international interdisciplinary journal of the American Cancer Society, publishes high-impact, peer-reviewed original articles and solicited content on the latest clinical research findings. (hdomst.hr)
  • After residency and chief residency with the University of Rochester/Highland Hospital Family Medicine Residency Program, she served on the faculty of the residency program from 2011-2014. (rochester.edu)
  • He was also the Chairman of Oncology Services & Director Oncology at Galaxy Cancer Institute, Pushpanjali Crosslay Hospital, Vaishali, Ghaziabad. (wellnessdestinationindia.com)
  • 5. Medical Visa Assistance: Once the patient is satisfied with the recommended treatment and hospital and has finalised their plans to visit India, we will assist them in obtaining a medical visa. (wellnessdestinationindia.com)
  • Attila Nemeth is a thoracic surgeon and currently serves as the attending thoracic surgeon and vice chief of the Thoracic surgery section at the University hospital Tübingen, Germany. (aats.org)
  • AWARE-1's elegant paired-biopsy design allows us to assess the impact of pelareorep on each patient's tumor immune environment, and the results to date have been very promising," said Dr. Aleix Prat, M.D., PhD., Translational Investigator of the Study, SOLTI President and Head of the Medical Oncology Department at Hospital Clinic in Barcelona. (financialnewsmedia.com)
  • I believe that tivozanib represents a potential therapeutic advance in the treatment of advanced kidney cancer," said Cora Sternberg, M.D., FACP, chief of medical oncology at San Camillo Forlanini Hospital, Rome, and TIVO-1 investigator. (aveooncology.com)
  • In addition to her clinical work for the Center for Primary Care, she leads a sexual medicine clinic in the University's Department of Gynecologic Oncology. (rochester.edu)
  • More broadly, Dr. Kishan is the Vice Chair of Clinical and Translational Research in the Department of Radiation Oncology at UCLA and oversees the clinical research apparatus for that Department. (uclahealth.org)
  • Dr. Steven Yevich, M.D., M.P.H. is an Interventional Radiologist with advanced fellowship training in Interventional Oncology from both Johns Hopkins University in Baltimore and Gustave Roussy Cancer Campus Grand Paris in France. (mdanderson.org)
  • FOSTER CITY, Calif.--( BUSINESS WIRE )--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced poster presentations of data from IMerge, the Company's Phase 3 clinical trial evaluating its first-in-class investigational telomerase inhibitor imetelstat vs. placebo in patients with lower risk myelodysplastic syndromes (MDS) at the eleventh annual Society of Hematologic Oncology Annual Meeting (SOHO) held in Houston, Texas and virtually. (businesswire.com)
  • Until recently, he was the Group Chief Operating Officer at Telix Pharmaceuticals (ASX:TLX) a global biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. (oncosil.com)
  • GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. (Sierra Oncology), a California-based biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer. (gsk.com)
  • Mr. Aromando has served in C-level roles for 15 years across multiple oncology-focused biopharmaceutical companies. (researchpool.com)
  • He brings extensive experience at biopharmaceutical companies with an oncology focus and a strong track record in corporate development, clinical drug development, partnerships, and overall operational excellence. (researchpool.com)
  • Adapting to the changes, societies such as the American Society of Clinical Oncology, Gastrointestinal Cancers Symposium, and European Society for Medical Oncology have adopted virtual and hybrid formats that deliver cutting-edge research in the advancement of oncology care. (ccanewsonline.com)
  • Statistically significant and clinically meaningful reductions in pain were observed with nirogacestat compared with placebo at Cycle 10 across all three assessment tools evaluated in DeFi: the Brief Pain Inventory-Short Form (BPI-SF), the GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom Scale (GODDESS-DTSS), and the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30). (tmcnet.com)
  • The study utilized The European Organization for Research and Treatment of Cancer Quality of Life questionnaire-C30 and showed no statistically significant difference in median time to deterioration for global health status and various functional scales between patients who received TTFields therapy and those who received standard systemic therapies alone. (latestnews.top)
  • Subsequently, he was Executive Vice President, Global Head of Oncology Research and Development at Daiichi Sankyo and developed ENHERTU. (sciencebusiness.net)
  • Moreover, he leads/co-leads the European Society of Hyperthermic Oncology, the Sarcoma and GIST Working Group of the AIO, the Sarcoma Study Group of the Bavarian Cancer Research Center (BZKF), the Certification Commission of the German Sarcoma Centers, and the Project Group Bone and Soft Tissue Sarcoma of the Munich Cancer Center. (wivb.com)
  • Medical Radiation Physics is a vast and complex translational research topic that deals with radiation physics applied to medicine and biology for medical radiation imaging and radiation therapy. (su.se)
  • He has been in charge of patient care delivery and medical strategic planning, as well as leading clinical and translational research programmes. (catalannews.com)
  • The European Journal of Oncology Nursing is an international journal which publishes research of direct relevance to patient care, nurse education, management and policy development. (hdomst.hr)
  • Each issue of Cancer strives to be comprehensive, spanning the breadth of oncology disciplines and providing something for everyone involved in cancer research, risk reduction, treatment, and patient care. (hdomst.hr)
  • He conceives research as a service to society, in that by improving our understanding of and looking for potential solutions to health issues we can guarantee a better future. (incliva.es)
  • He is currently participating in research projects funded by the national Carlos III Health Institute, the Ministry of Health and the European Union, as well as by other public and private entities. (incliva.es)
  • A CDK4/6 inhibitor combined with a hormone-blocking drug is now the standard first-line treatment for postmenopausal women with this form of advanced breast cancer, explained Stanley Lipkowitz, M.D., Ph.D., chief of the Women's Malignancies Branch in NCI's Center for Cancer Research. (cancer.gov)
  • These data were presented today by Dmitry A. Nosov, M.D., Ph.D., senior clinical researcher at the Blokhin Oncology Research Center, Moscow, Russian Federation, in an oral presentation titled, "Phase 2 Randomized Discontinuation Trial (RDT) of Tivozanib in Patients With Renal Cell Carcinoma (RCC): Results in Patients Randomized to Tivozanib vs. Placebo. (aveooncology.com)
  • This work has received extensive funding support from the Jonsson Comprehensive Cancer Center, the Specialized Program of Research Excellence (SPORE) for Prostate Cancer (via the NIH), the STOP Cancer organization, Radiological Society of North America, the Radiation Oncology Institute, the American Society for Radiation Oncology, and the Prostate Cancer Foundation (PCF). (uclahealth.org)
  • At International Society for Stem Cell Research-the big stem cell meeting-Yamanaka revealed one more factor. (medscape.com)
  • Dr Mirza gained his degree in Medicine with honours in 1985, a Diploma in Surgery in 1986 and a Diploma in Clinical Oncology in 1988 from the Pirogov Moscow State Medical Institute. (esmo.org)
  • In 1994 he gained his License to practice medicine in Denmark (National Board of Health), in 1996 a Post graduation in Clinical Oncology from the University of Southern Denmark and his License to practice Medical & Radiation Oncology in Denmark (National Board of Health). (esmo.org)
  • During medical school, she was thrilled to discover family medicine as she is most interested in caring for whole people, families, and communities. (rochester.edu)
  • After serving as chief resident, she joined the faculty in 2011 with a focus on teaching in the psychosocial medicine curriculum. (rochester.edu)
  • Sexual medicine, simply put, addresses the sexual aspects of medical issues and the medical aspects of sexual issues. (rochester.edu)
  • Subsequently she pursued further training in the new field of sexual medicine through the European Society of Sexual Medicine, the International Society for the Study of Women's Sexual health, and the American Association of Sexuality Educators, Counselors, and Therapists. (rochester.edu)
  • As previously announced , the acquisition of Sierra Oncology includes momelotinib, a late-stage potential new medicine with a unique dual mechanism of action that may address the critical unmet medical needs of myelofibrosis patients with anaemia. (gsk.com)
  • The New England Journal of Medicine (NEJM) is recognized as the world's leading medical journal and website. (hdomst.hr)
  • Immune Design has received Orphan Drug Designation for CMB305 from the U.S. Food and Drug Administration (FDA) for the treatment of soft tissue sarcoma, as well as from the FDA and European Medicines Agency for each of the components of CMB305 for the treatment of soft tissue sarcoma. (biospace.com)
  • Junshi Biosciences also submitted a MAA to the European Medicines Agency ("EMA") for toripalimab for the same indications in mid-November. (itbusinessnet.com)
  • We are running several collaborative projects with colleagues in the Departments of Urology, Human Genetics, Pathology, Medical Oncology, and Statistics to help develop and validate biomarkers that can help personalize treatment decisions. (uclahealth.org)
  • We have published preliminary work in journals such as European Urology . (uclahealth.org)
  • Multiple high-profile publications have emerged from this work, including publications in JAMA, JAMA Oncology, and European Urology , and several publications are referenced in the National Comprehensive Cancer Network guidelines for prostate cancer treatment. (uclahealth.org)
  • He gave lectures on the peripheral neurotoxicity of anticancer drugs at American Academy of Neurology, American Society for Clinical Oncology and European Society for Medical Oncology meetings, as well as at FDA and EMA boards on toxic neuropathies and trials design. (hstalks.com)
  • Carole Ferrand is currently Chief Financial Officer of the Capgemini Group and Director of Fnac Darty. (sciencebusiness.net)
  • During his tenure as Group Chief Financial Officer at Telix Pharmaceuticals Limited (ASX:TLX), he was a key member of the team which successfully completed the IPO, raised $270 million in capital and grew the business to a multi‐billion dollar market capitalisation. (oncosil.com)
  • Mr. O'Connor continued, "I would also like to thank Sonja Nelson for serving as both Chief Financial Officer and Chief Operating Officer over the past several months. (researchpool.com)
  • He also served on the Editorial Board of the Journal of Clinical Oncology. (wivb.com)
  • His speciality is Medical and Radiation Oncology. (esmo.org)
  • When Lorraine Griggs' 86-year-old father was diagnosed with prostate cancer, he was treated with 35 rounds of radiation, though he had a long list of other serious medical issues, including diabetes, kidney disease and high blood pressure. (kuer.org)
  • These important results in people with metastatic triple-negative breast cancer whose disease expresses the PD-L1 protein are highly encouraging and represent a significant step forward in the treatment of this challenging disease," said Sandra Horning, M.D., chief medical officer and head of Global Product Development. (azbio.org)
  • Stay informed on the latest advances in medical literature, by regulatory agencies like the FDA, and from 200+ medical conferences worldwide. (medscape.com)
  • Within a single month, we were able to submit marketing authorization applications for toripalimab to two major European regulatory agencies," said Dr. Patricia Keegan, Chief Medical Officer of Junshi/TopAlliance Biosciences. (itbusinessnet.com)
  • He is also a member of both the German and European Society for Thoracic Surgeons. (aats.org)
  • Navigate the complex business, legal, and ethical arenas towards building and maintaining a successful medical practice. (medscape.com)
  • The U.S. drugmaker's drug Keytruda reduced the risk of death or cancer progression by 50 percent, Merck said, unveiling details of a crucial study at a meeting of the European Society for Medical Oncology. (lifeboat.com)
  • Active biotech and pharma companies in the markets this week include Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), Aptevo Therapeutics Inc. (NASDAQ: APVO), Cardiff Oncology, Inc. (NASDAQ: CRDF), Halozyme Therapeutics, Inc. (NASDAQ: HALO), Merck (NYSE: MRK). (financialnewsmedia.com)
  • Dr. Kranz completed post-baccalaureate studies at Goucher College in 2003 and returned to her undergraduate alma mater, Brown University, for medical school. (rochester.edu)
  • Head of the Experimental Neurology Unit and of the PhD program in Neuroscience, University of Milano-Bicocca, deputy Chief Scientific Officer, Milan Center for Neuroscience. (hstalks.com)
  • He is also the Co-Director of the Thoracic Oncology Program at the Keck and Norris Hospitals of the University of Southern California. (aats.org)
  • Rochester Center for Sexual Wellness is a unique resource in Western New York offering comprehensive medical and mental health evaluation and treatment for sexual concerns in people of all genders. (rochester.edu)
  • He is co-founder and non-executive board member of the Hartwig Medical Foundation (large scale DNA analyses) and is a board member of the Center for Personalized Cancer Treatment and leads several innovative precision oncology clinical trials. (sciencebusiness.net)